The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the ClinicalTrials.gov link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.
You can also contact the CTN coordinating centre for additional information: ECFS-CTN@uzleuven.be (link sends e-mail)
| Study Name on ClinicalTrials.gov (link is external) | A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects |
|---|---|
| Study Drug | Inhaled mannitol |
| Type of Study Drug | Restore Airway Surface Liquid |
| Study Title | Long Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects |
| Study Phase | 3 |
| Study Sponsor | Pharmaxis |
http://clinicaltrials.gov/ct2/show/NCT02134353 (link is external) | |
| Participating ECFS-CTN sites | Belgium: Leuven France: Bordeaux, Toulouse, Reims, Strasbourg, Lyon, Marseille, Montpellier, Rennes, West-Paris (Cochin) Italy: Rome, Verona |
| Age | 18 Years and older |